New serums take on hydroquinone in skin brightening showdown
NCT ID NCT07644871
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This 4-week pilot study tested two brightening serums against 4% hydroquinone in 18 adults with hyperpigmentation or melasma. Each participant used different products on each side of their face to compare results. The goal was to see if the serums could improve skin tone evenness and reduce dark spots.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- brightening serums (cosmetics) and 4% hydroquinone
- What this could lead to
- If successful, these serums could offer a gentler alternative to hydroquinone for evening skin tone and reducing dark spots.
- What could go wrong
- This is a very small, short pilot study with only 18 participants, so results may not apply widely. Cosmetics are less regulated than drugs, and effectiveness may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DARK SPOTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Revision Skincare
Irving, Texas, 75063, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new laser erase acne scars without harming darker skin?
- Can a simple pill make melasma creams work better?
- Can a two-acid cream fade stubborn melasma?
- Green tea compound EGCG put to the test for clearer, more hydrated skin
- A skin biostimulator aims to reverse sun damage without the peel downtime
- Can sunscreen do more than protect? study tests if it fades dark spots